Sponsor Pipeline

Everfront Biotech Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
0
Recruiting
1
Phase 3
3
Disease Areas
Active Trials by Phase
Phase 2/3
1
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT07349693 Comparison of Cerebraca Wafer Plus Temozolomide Versus Temozolomide Alone in Recurrent… Recurrent Glioblastoma, IDH-Wildtype Not Yet Recruiting
Phase 1/2
NCT04381130 A Phase I/IIa Study of EF-009 in Patients with Pancreatic Cancer Pancreatic Cancer Not Yet Recruiting
Phase 1
NCT03651349 To Determine the Maximum Tolerated Dose (MTD) of HK-001 in Healthy Volunteers Amyotrophic Lateral Sclerosis Active, Not Recruiting
Disease Areas
ALS (1) Pancreatic Cancer (1) Glioblastoma (1)
Get alerts when Everfront Biotech Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free